Luckys Pharma Lab Private Limited

Razin DSR is a combination of Rabeprazole Sodium and Domperidone, formulated to provide effective relief from various gastrointestinal conditions. Rabeprazole Sodium, a potent proton pump inhibitor (PPI), works by reducing the production of stomach acid. This action helps in the treatment and management of conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders, offering relief from symptoms such as heartburn, acid reflux, and discomfort.

Domperidone, a prokinetic agent, complements the action of Rabeprazole by enhancing gastrointestinal motility. It helps in improving the movement of food through the stomach and intestines, reducing symptoms like nausea, vomiting, bloating, and a feeling of fullness. Domperidone is particularly effective in managing symptoms related to delayed gastric emptying, which can often accompany acid-related conditions.

Together, Rabeprazole Sodium and Domperidone in Razin DSR provide a dual-action approach to managing acid-related disorders and associated symptoms, making it a comprehensive solution for patients seeking relief from gastrointestinal discomfort.

Efurt 250/500 is a broad-spectrum antibiotic medication containing Cefuroxime Axetil, available in 250 mg and 500 mg tablet formulations. Cefuroxime Axetil is a cephalosporin antibiotic that works by disrupting the synthesis of bacterial cell walls, ultimately leading to the destruction of bacteria. This makes Efurt 250/500 highly effective against a wide range of bacterial infections.

Efurt 250/500 is used to treat various infections, including those affecting the respiratory tract (such as bronchitis and pneumonia), urinary tract infections, skin and soft tissue infections, and infections of the ear, nose, and throat. Its broad spectrum of activity makes it suitable for managing both uncomplicated and more severe infections caused by susceptible bacteria.

The dosage flexibility of Efurt 250/500 allows for tailored treatment plans based on the severity of the infection and the patient’s overall health. By providing a reliable and effective antibiotic option, Efurt 250/500 helps ensure prompt recovery from bacterial infections and prevents complications associated with untreated infections.

Levoice D is a dual-action medication that combines Montelukast and Desloratadine, formulated to provide comprehensive relief from allergic rhinitis and related respiratory conditions. Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, substances in the body that cause inflammation, bronchoconstriction, and mucus production. This helps to prevent and manage symptoms such as wheezing, shortness of breath, and chest tightness, making it particularly effective for individuals with asthma or seasonal allergies.

Desloratadine, the second component, is a potent antihistamine that effectively combats symptoms like sneezing, runny nose, itchy or watery eyes, and skin hives. It works by blocking histamine, a substance in the body that causes allergic reactions, providing fast and long-lasting relief without causing drowsiness.

Levoice D is designed to address both the immediate and underlying causes of allergic symptoms, making it an ideal choice for those seeking a comprehensive approach to managing their respiratory and allergic conditions. This combination ensures that patients not only experience relief from current symptoms but also receive protection against future allergic reactions, promoting better respiratory health and overall well-being.

Levoice D is a dual-action medication that combines Montelukast and Desloratadine, formulated to provide comprehensive relief from allergic rhinitis and related respiratory conditions. Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, substances in the body that cause inflammation, bronchoconstriction, and mucus production. This helps to prevent and manage symptoms such as wheezing, shortness of breath, and chest tightness, making it particularly effective for individuals with asthma or seasonal allergies.

Desloratadine, the second component, is a potent antihistamine that effectively combats symptoms like sneezing, runny nose, itchy or watery eyes, and skin hives. It works by blocking histamine, a substance in the body that causes allergic reactions, providing fast and long-lasting relief without causing drowsiness.

Levoice D is designed to address both the immediate and underlying causes of allergic symptoms, making it an ideal choice for those seeking a comprehensive approach to managing their respiratory and allergic conditions. This combination ensures that patients not only experience relief from current symptoms but also receive protection against future allergic reactions, promoting better respiratory health and overall well-being.

Divoteas 250/500 is a medication containing Divalproex Sodium, available in 250 mg and 500 mg tablet formulations. Divalproex Sodium is a versatile anticonvulsant and mood-stabilizing drug used primarily in the management of epilepsy, bipolar disorder, and migraine prophylaxis. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, a neurotransmitter that helps to calm excessive nerve activity, thus reducing the frequency and severity of seizures and stabilizing mood swings.

In epilepsy, Divoteas helps control various types of seizures, including generalized tonic-clonic, absence, and partial seizures. For individuals with bipolar disorder, it assists in managing manic episodes and stabilizing mood, preventing extreme mood swings. Additionally, Divoteas is effective in preventing migraines, reducing the frequency of headache episodes and associated symptoms.

The flexibility of dosing with Divoteas 250/500 allows for precise management tailored to the patient’s specific needs and condition severity. This makes Divoteas a reliable option for those seeking effective control of seizure disorders, mood stabilization, and migraine prevention, ultimately enhancing the quality of life and overall well-being.

Medine 4/8 is a potent corticosteroid medication containing Methylprednisolone, available in 4 mg and 8 mg tablet formulations, designed to manage a broad spectrum of inflammatory and autoimmune conditions. Methylprednisolone is renowned for its powerful anti-inflammatory and immunosuppressive effects, making it a critical treatment option for conditions such as rheumatoid arthritis, lupus, severe allergies, asthma, and certain skin disorders. By reducing inflammation and modulating the immune system, Medine 4/8 helps alleviate symptoms like pain, swelling, redness, and allergic reactions, providing significant relief to patients suffering from chronic and acute conditions.

Medine 4/8 is also widely used in managing flare-ups of chronic diseases, ensuring that patients experience reduced severity and duration of symptoms. Additionally, it plays a crucial role in preventing organ rejection in transplant patients by suppressing the immune response. The flexibility of dosing with Medine 4 and 8 mg tablets allows for personalized treatment plans, ensuring that each patient receives the appropriate dosage to effectively manage their condition.

Medine 4/8 is a potent corticosteroid medication containing Methylprednisolone, available in 4 mg and 8 mg tablet formulations, designed to manage a broad spectrum of inflammatory and autoimmune conditions. Methylprednisolone is renowned for its powerful anti-inflammatory and immunosuppressive effects, making it a critical treatment option for conditions such as rheumatoid arthritis, lupus, severe allergies, asthma, and certain skin disorders. By reducing inflammation and modulating the immune system, Medine 4/8 helps alleviate symptoms like pain, swelling, redness, and allergic reactions, providing significant relief to patients suffering from chronic and acute conditions.

Medine 4/8 is also widely used in managing flare-ups of chronic diseases, ensuring that patients experience reduced severity and duration of symptoms. Additionally, it plays a crucial role in preventing organ rejection in transplant patients by suppressing the immune response. The flexibility of dosing with Medine 4 and 8 mg tablets allows for personalized treatment plans, ensuring that each patient receives the appropriate dosage to effectively manage their condition.

FlownXYN Nasal Spray contains Xylometazoline, a fast-acting decongestant that provides quick relief from nasal congestion caused by colds, sinusitis, and allergies. Xylometazoline works by constricting the blood vessels in the nasal passages, reducing swelling and opening up the airways to promote easier breathing.

FlownXYN Nasal Spray is ideal for those suffering from blocked nasal passages, offering rapid and long-lasting relief with just a few sprays. It helps users breathe more freely by reducing nasal congestion, making it especially effective during cold and allergy seasons. Safe and easy to use, FlownXYN Nasal Spray provides targeted relief directly to the nasal area for fast-acting comfort.

TROPIUM-LS Keyhaler: Dual Bronchodilator Therapy for Respiratory Relief

TROPIUM-LS Keyhaler combines Ipratropium Bromide 40 mcg and Levosalbutamol 100 mcg to provide effective relief from bronchospasms associated with asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. Ipratropium Bromide, a short-acting muscarinic antagonist (SAMA), works by relaxing airway muscles and reducing bronchial secretions, promoting better airflow. Levosalbutamol, a short-acting beta-agonist (SABA), provides rapid bronchodilation, relieving acute breathing difficulties and reducing airway resistance.